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Abstract
Mouse oocytes and zygotes, when solubilised demonstrated that a range of ketoaldehydes could be utilised as substrates.
Of the five ketoaldehydes investigated the overall substrate utilisation was hydroxypyruvate)glyoxylate)2-ketobutyrate
)pyruvate)glycolate. The utilisation of these ketoaldehydes during early development by LD-1 may provide a source of
new metabolic substrates in addition to the potential control of aldehyde toxicity. It is proposed therefore that the LD-1
isoenzyme is responsible for ketoaldehyde utilisation prior to implantation thereby providing a source of alternative
metabolic substrates for the developing embryo.
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Previous research has demonstrated that cumulus
oophorus free oocytes and zygotes have lactate dehy-
 .drogenase LD; EC: 1.1.1.27 activity well in excess
w xof that normally expected for cell size 1 . Despite the
high activity of this enzyme in the oocytes and
zygotes subsequent research demonstrated that LD
w xexists only in the LD-1 isoform 2 . This LD isoform
favours the aerobic conversion of pyruvate to lactate
and has been related to the almost exclusive reliance
of the oocyte and zygote on pyruvate as its sole
w xenergy source at this stage of development 3,4 . As
LD-1 is inhibited by high pyruvate concentrations it
seems improbable that high enzyme activity is in
w xresponse to high pyruvate concentrations 5 How-
ever, there are problems reconsiling the avascular
environment of the ovary and oviduct with the exis-
tance of the LD-1 isoenzyme. LD is an ubiquitous
enzyme, being able to utilise a range of ketoaldehyde
) Corresponding author. Fax: q64 3 4797866.
w xsubstrates 6 . In this communication the oocyte and
zygote enzymatic utilisation of a range of ketoalde-
hyde substrates is reported which may provide further
insights into early oocyte and embryo metabolism.
 .Oocytes and zygotes 1-cell fertilised embyros
were obtained from BALBrcJ female mice aged 6 to
10 weeks following superovulation with intraperi-
toneal injections of pregnant mares serum go-
 .nadotrophin PMSG and human chorionic go-
 . w xnadotrophin hCG given 48 h apart 7 . Oocytes
were collected from the oviducts 18 h following hCG
injection and zygotes were collected following suc-
cessful mating with male mice. Both oocytes and
zygotes were collected into Hanks balanced salt solu-
tion, the cumulus oophorus removed using bovine
testicular hyaluronidase, then the oocytes and zygotes
were washed in three changes of HTF embryo culture
w xmedium 8 at 378C. They were then transferred to
fresh HTF medium and maintained at 378C in a 5%
carbon dioxide in air incubator until analysis. Imme-
diately prior to analysis both oocyte and zygote qual-
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ity was determined based on morphology and unsatis-
factory oocytes and zygotes discarded.
Substrate utilisation was determined spectrophoto-
metrically at 308C based on the lactate dehydroge-
w xnase method of Hewell et al. 9 . Briefly 100 ml of
sample buffer containing 10 oocytes or zygotes was
pipetted into 2.5 cm3 of reaction mixture containing
substrate, buffer and NADH at pH 7.4. The reaction
was followed for 5 min at 340 nm, read against a
control oocytes or zygotes plus reaction mixture
.minus NADH in a LKB Ultraspec II spectrophotom-
eter. The extinction change per min was determined
and used to calculate the substrate utilisation using
the extinction coefficient of NADH. The ketoaldehy-
 .des investigated were: hydroxypyruvate 0.14 mmol ;
 .  .glyoxylate 20 mmol ; 2-ketobutyrate 15 mmol ;
 .  .pyruvate 10 mmol and glycolate 12.5 mmol , sub-
strate concentration is in parentheses. Six individual
assays, each comprising of 10 oocytes or zygotes in
100 ml of sample buffer were analysed. The mean
and SD for the results was calculated.
The results expressed as mmol substrate
.utilisedrmin per embryo or oocyte for the five
ketoaldehyde substrates are shown in Table 1.
There was considerable variation in the utilisation
of the substrates with hydroxypyruvate producing the
highest activity and glycolate the lowest activity.
Overall substrate utilisation was hydroxypyruvate)
glyoxylate ) 2-ketobutyrate ) pyruvate ) glycolate.
There was no variation between oocytes and zygotes
in the utilisation of these substrates.
These investigations indicate that enzymatic activ-
ity from both the oocyte and zygote can utilise a wide
range of ketoaldehyde substrates. Due to the ubiqui-
Table 1
Ketoaldehyde utilisation by oocytes and zygotes
Substrate n Mean rate of utilisation mmolr
y1 . .mmolPl min per oocytes or zygote
Oocyte Zygote
Hydroxypyruvate 6 64.5"6.0 63.2"6.6
Glyoxylate 6 57.4"5.1 59.7"4.0
2-ketobutyrate 6 59.3"2.9 57.8"3.5
Pyruvate 6 28.7"1.8 26.5"2.9
Glycolate 6 0.9"0.32 1.3"0.27
nssix individual assays each comprising of 10 oocytes or
zygotes in 100 ml sample buffer.
"SD.
tous substrate nature of LD-1 and its high activity on
both oocytes and zygotes calculated to represent five
per cent of the total protein at this stage of develop-
w x.ment 1 , it is proposed that LD-1 is the most likely
candidate enzyme for the broad range of ketoalde-
hyde substrate utilisation identified in the current
work.
Four of the five substrates investigated can poten-
tially provide new metabolic substrates. Hydrox-
ypyruvate is reduced to form glycerate; 2-keto-
butyrate is reduced to form 2-hydroxybutyrate
 .crotonyl CoA precursor ; glyoxylate is reduced to
malate or may provide a substrate for glycerate. The
poor utilisation of glycolate as a substrate indicates
lack of specificity for this ketoaldehyde. In addition
to the potential to utilise ketoaldehydes as substrates,
the control of these potentially toxic compounds
would seem imperative as they are acknowledged
w xinhibitors of cell growth 10 and can auto-oxidise to
form reactive chemical species such as superoxide or
w xhydroxyl radicals 11 .
Little is still known about early mammalian em-
w xbryo metabolism 4 and nutritional requirements
w x4,12,13 . However, oocyte and zygote existence in
the avascular environment of both the ovary and
oviduct prior to ovulation and at fertilisation, plus the
rapid changes in gene activation and cellular develop-
ment for the early embryo must place exceptional
metabolic requirements on these cells. The utilisation
 .of ketoaldehydes via a common pathway LD-1
provides for metabolic economy to provide new
metabolic substrates as well as the control of poten-
tial inhibitors to cellular function.
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